Regulatory Excellence CriTech’s 30+ years of focus on medical device software, ISO 13485:2016 certification, and 100% first-time approval rate for FDA and EU submissions indicate a strong regulatory track record. This positions them as a trusted partner for medtech firms seeking efficient compliance and submission success.

Strategic Partnerships Recent collaborations with Parasoft UK Ltd and The Realtime Group signal an active expansion strategy through alliances. This suggests opportunities to upsell joint offerings, integrate automated testing capabilities, and access broader client networks in regulated device development.

SaMD & Safety Expertise Specialization in medical device software across safety classifications (IEC 62304) and SaMD, plus capabilities in risk management, cybersecurity, AI/ML, and UI/core software development, creates cross-sell potential to manufacturers pursuing end-to-end compliance and modern software features.

Quality & Due Diligence Free project analysis and due diligence consulting services position CriTech as a low-risk entry point for medtech firms evaluating software development partners, enabling faster engagement and larger multi-project commitments.

Financial & Market Fit With revenue in the mid tens of millions and a focused industry footprint, CriTech offers scalable engagement models for mid-sized medical device manufacturers seeking compliant software solutions, presenting an opportunity to expand within a constrained, specialized market.